Case Study: Identification and Monitoring of Problematic HCPs for Improved Process Development

Home > Science Hub > Case Study: Identification and Monitoring of Problematic HCPs for Improved Process Development
Back to the list

October 21, 2019

DOWNLOAD OUR CASE STUDY

Case Study HCP-cover

GET A RELIABLE, COMPREHENSIVE INVENTORY OF RESIDUAL
HCP IN YOUR PROCESS INTERMEDIATES AND FINAL DRUG SUBSTANCE

Contact us to get your project started

HCP Detect™ Contact

You might also be interested by

Brochures

Cell Therapy

December 15, 2023

Histopathology

More info

Brochures

Immuno-MRM Assays

August 4, 2023

Proteomics/Mass Spectrometry

More info

Webcasts & Webinars

Precision Oncology Approaches: Using Proteomics to Build Next-Gen Diagnostic Solutions

May 2, 2023

Proteomics/Mass Spectrometry

More info

Posters

Analytical characterization of a multiplex panel measuring 45 cytokines by proximity extension assay in plasma from subjects with NSCLC

April 17, 2023

Proteomics/Mass Spectrometry

More info